Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550–61. https://doi.org/10.1016/S0140-6736(09)60237-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeiser R, Blazar BR. Acute graft-versus-host disease—biologic process, prevention, and therapy. N Engl J Med. 2017;377(22):2167–79. https://doi.org/10.1056/NEJMra1609337.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnes DW, Loutit JF. Treatment of murine leukaemia with x-rays and homologous bone marrow. II. Br J Haematol. 1957;3(3):241–52. https://doi.org/10.1111/j.1365-2141.1957.tb05793.x.

Article  CAS  PubMed  Google Scholar 

Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411(6835):385–9. https://doi.org/10.1038/35077251.

Article  CAS  PubMed  Google Scholar 

Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25:139–70. https://doi.org/10.1146/annurev.immunol.25.022106.141606.

Article  CAS  PubMed  Google Scholar 

Ghimire S, Weber D, Mavin E, Wang XN, Dickinson AM, Holler E. Pathophysiology of GvHD and other HSCT-related major complications. Front Immunol. 2017;8:79. https://doi.org/10.3389/fimmu.2017.00079.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertaina A, Roncarolo MG. Graft engineering and adoptive immunotherapy: new approaches to promote immune tolerance after hematopoietic stem cell transplantation. Front Immunol. 2019;10:1342. https://doi.org/10.3389/fimmu.2019.01342.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gooptu M, Koreth J. Translational and clinical advances in acute graft-versus-host disease. Haematologica. 2020;105(11):2550–60. https://doi.org/10.3324/haematol.2019.240309.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Billingham RE. The biology of graft-versus-host reactions. Harvey Lect. 1966;62:21–78.

PubMed  Google Scholar 

Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer. 2004;4(5):371–80. https://doi.org/10.1038/nrc1365.

Article  CAS  PubMed  Google Scholar 

Jagasia M, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119(1):296–307. https://doi.org/10.1182/blood-2011-06-364265.

Article  CAS  PubMed  PubMed Central  Google Scholar 

MacMillan ML, et al. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biol Blood Marrow Transplant. 2015;21(4):761–7. https://doi.org/10.1016/j.bbmt.2015.01.001.

Article  PubMed  PubMed Central  Google Scholar 

Martin PJ, et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2012;18(8):1150–63. https://doi.org/10.1016/j.bbmt.2012.04.005.

Article  PubMed  PubMed Central  Google Scholar 

Martin PJ. How I treat steroid-refractory acute graft-versus-host disease. Blood. 2020;135(19):1630–8. https://doi.org/10.1182/blood.2019000960.

Article  PubMed  Google Scholar 

Westin JR, et al. Steroid-refractory acute GVHD: predictors and outcomes. Adv Hematol. 2011;2011: 601953. https://doi.org/10.1155/2011/601953.

Article  PubMed  PubMed Central  Google Scholar 

Toubai T, Magenau J. Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease. Blood. 2020;136(4):429–40. https://doi.org/10.1182/blood.2019000953.

Article  PubMed  PubMed Central  Google Scholar 

Khoury HJ, et al. Improved survival after acute graft. Haematologica. 2017;102(5):958–66. https://doi.org/10.3324/haematol.2016.156356.

Article  PubMed  PubMed Central  Google Scholar 

Malard F, Huang XJ, Sim JPY. Treatment and unmet needs in steroid-refractory acute graft-versus-host disease. Leukemia. 2020;34(5):1229–40. https://doi.org/10.1038/s41375-020-0804-2.

Article  PubMed  PubMed Central  Google Scholar 

Gooptu M, Antin JH. GVHD Prophylaxis 2020. Front Immunol. 2021;12: 605726. https://doi.org/10.3389/fimmu.2021.605726.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abboud R, et al. Insights into the role of the JAK/STAT signaling pathway in graft-. Ther Adv Hematol. 2020;11:2040620720914489. https://doi.org/10.1177/2040620720914489.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi J, et al. Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect. PLoS ONE. 2014;9(10): e109799. https://doi.org/10.1371/journal.pone.0109799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeiser R, et al. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey. Leukemia. 2015;29(10):2062–8. https://doi.org/10.1038/leu.2015.212.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spoerl S, et al. Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease. Blood. 2014;123(24):3832–42. https://doi.org/10.1182/blood-2013-12-543736.

Article  CAS  PubMed  Google Scholar 

Choi J, et al. Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease. Leukemia. 2018;32(11):2483–94. https://doi.org/10.1038/s41375-018-0123-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashami K, DiPersio JF, Choi J. Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD. Oncotarget. 2018;9(87):35721–2. https://doi.org/10.18632/oncotarget.26291.

Article  PubMed  PubMed Central  Google Scholar 

Schroeder MA, Choi J, Staser K, DiPersio JF. The role of janus kinase signaling in graft-versus-host disease and graft versus leukemia. Biol Blood Marrow Transplant. 2018;24(6):1125–34. https://doi.org/10.1016/j.bbmt.2017.12.797.

Article  CAS  PubMed  Google Scholar 

Jagasia M, Zeiser R, Arbushites M, Delaite P, Gadbaw B, Bubnoff NV. Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials. Immunotherapy. 2018;10(5):391–402. https://doi.org/10.2217/imt-2017-0156.

Article  CAS  PubMed  Google Scholar 

Jagasia M, et al. Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial. Blood. 2020;135(20):1739–49. https://doi.org/10.1182/blood.2020004823.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeiser R, et al. Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial. Lancet Haematol. 2022;9(1):e14–25. https://doi.org/10.1016/S2352-3026(21)00367-7.

Article  CAS  PubMed  Google Scholar 

Schroeder MA, et al. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease. Blood Adv. 2020;4(8):1656–69. https://doi.org/10.1182/bloodadvances.2019001043.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harris AC, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount Sinai acute GVHD international consortium. Biol Blood Marrow Transplant. 2016;22(1):4–10. https://doi.org/10.1016/j.bbmt.2015.09.001.

Article  PubMed  Google Scholar 

Hamilton BK. Updates in chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program. 2021;2021(1):648–54. https://doi.org/10.1182/hematology.2021000301.

Article  PubMed  PubMed Central  Google Scholar 

Cooke KR, et al. The biology of chronic graft-versus-host disease: a task force report from the national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017;23(2):211–34. https://doi.org/10.1016/j.bbmt.2016.09.023.

Article  PubMed  Google Scholar 

Schroeder MA, DiPersio JF. Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech. 2011;4(3):318–33. https://doi.org/10.1242/dmm.006668.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hill GR, Koyama M. Cytokines and costimulation in acute graft-versus-host disease. Blood. 2020;136(4):418–28. https://doi.org/10.1182/blood.2019000952.

Article  PubMed